Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynectics Regulatory News (SNX)

Share Price Information for Synectics (SNX)

Share Price is delayed by 15 minutes
Get Live Data
200.00    0.00 (0.00%)
Bid:
195.00
Ask:
205.00
Spread: 10.00 (5.128%)
Market Cap: £34.01m
SNX Live PriceLast checked at - London Stock Exchange

Intraday Synectics Share Chart

Trading Update

16 Oct 2025 07:01

RNS Number : 5649D
Synectics PLC
16 October 2025
Β 

This announcement contains inside information for the purpose of the assimilated Market Abuse Regulation (EU) 596/2014 as it forms part of the law of the United Kingdom by virtue of the European Union (Withdrawal) Act 2018, as amended.

16 October 2025

Β 

Β 

Β 

Β 

Synectics plc

("Synectics" of the "Company")

Β 

Trading Update

Β 

Synectics plc (AIM: SNX), a leader in advanced security and surveillance solutions, provides an update on trading for the year ending 30 November 2025 ("FY 2025, the "Period").

Β 

The Company is pleased to confirm that trading for FY 2025 is expected to deliver revenues of approximately Β£67m (FY24: Β£55.8m) and PBT of no less than Β£5.7m (excluding the share-based payment charge) (FY24: Β£4.7m).

Β 

Progress has been positive in the year to date, securing extensions and repeat orders with both new and existing long-term customers across a variety of sectors and geographies, in addition to successfully delivering a significant, non-recurring gaming contract in South-East Asia in the Period.

Β 

As outlined in the FY 2024 Annual Report and FY 2025 Interim Report, Synectics' refreshed growth strategy is focused on scaling the business sustainably through targeted investment in product development, and commercial and operational capabilities. The Company expects to increase investment in 2026, to support the Company's strategic growth ambitions and position Synectics to capitalise on substantial market opportunities ahead.

Β 

The Company continues to build a solid order book and has good visibility on its new business pipeline for FY 2026, supported by ongoing customer demand in growing markets. Recent contract wins in the renewables and decarbonisation sectors, announced today, reflect early traction from the Company's strategic initiatives to broaden its market reach and diversify its end markets.

Β 

With a strong balance sheet, a strengthening market position, and clear strategic priorities, the Board remains confident in Synectics' outlook and its ability to deliver long-term value creation.

Β 

Β 

For further information, please contact:

Β 

Synectics plc

Amanda Larnder, Chief Executive Officer

Paul Williams, Chief Financial Officer

email: info@synecticsplc.com

Tel: +44 (0) 114 280 2828

www.synecticsplc.com

Β 

Β 

Singer Capital Markets

Tel: +44 (0) 20 7496 3000

Jen Boorer / James Fischer / Patrick Weaver

Vigo ConsultingΒ Β 

Jeremy Garcia / Fiona Hetherington / Peter Jacob

synectics@vigoconsulting.com

Tel: +44 (0) 20 7390 0230

Β 

Β 

About Synectics plc

Synectics plc (AIM: SNX) is a leader in advanced security and surveillance solutions that help protect people, property and assets around the world.

Β 

It transforms customer operations by seamlessly integrating systems, technologies, and data into a unified solution-enhancing safety, improving efficiency, and enabling smarter, faster decision-making and response capabilities.

Β 

With its technical expertise, decades of experience, and strong partnerships, Synectics sets itself apart by delivering innovation and service that drive real value and long-term success.

Β 

Find out more at www.synecticsplc.com.

Β 

Β 

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
TSTFZMMGNKDGKZM
Date   Source Headline
25th Nov 20247:00 amRNSContract Awards
18th Nov 20247:00 amRNSAppointment of CEO and Award of Options
4th Nov 20247:00 amRNSContract Awards
3rd Oct 20247:00 amRNSHolding(s) in Company
3rd Oct 20247:00 amRNSHolding(s) in Company
2nd Oct 20247:00 amRNSPDMR dealings
16th Sep 20247:00 amRNSTrading Update
9th Sep 20247:00 amRNSUS$3.2 million contract award
4th Sep 20241:30 pmRNSPDMR Dealings
29th Aug 20247:00 amRNSPassing of Paul Webb, Chief Executive Officer
21st Aug 20247:00 amRNSNotifiable Interest in Shares
1st Aug 20241:45 pmRNSHoldings in Company
9th Jul 20244:40 pmRNSHoldings in Company
9th Jul 20247:00 amRNSHalf-year Report
21st Jun 20247:00 amRNSBoard Appointment
18th Jun 20247:00 amRNSUS$10 million contract win
13th Jun 202410:00 amRNSNotice of Investor Presentation
4th Jun 20247:00 amRNSTrading Update
15th May 20247:00 amRNSDirector/PDMR Dealings
24th Apr 202410:00 amRNSResult of AGM
24th Apr 20247:00 amRNSAGM Statement
17th Apr 20247:00 amRNSContract win with a major UK utility provider
9th Apr 20247:00 amRNSBoard Appointment and Grant of Options
3rd Apr 20247:00 amRNSDirector/PDMR Dealings
26th Mar 20247:00 amRNSDirectors / PDMRs' Interests in Shares
26th Mar 20247:00 amRNSDirector/PDMR Shareholding
19th Mar 20247:00 amRNSPosting of Annual Report & Accounts, Notice of AGM
27th Feb 20247:00 amRNSFinal Results
7th Feb 20247:00 amRNSNotice of Results and Investor Presentation
30th Jan 20247:00 amRNSContract Awards
19th Dec 20233:00 pmRNSHolding(s) in Company
11th Dec 20237:00 amRNSTrading Update
29th Nov 20237:00 amRNSContract Win
15th Nov 20237:00 amRNSInvestor Site Visit
23rd Oct 20237:00 amRNSDirectorate Changes
16th Oct 20237:00 amRNSLatest Release of Synectics’ Synergy Software
11th Oct 20237:00 amRNSDirector/PDMR Dealings
28th Sep 20237:00 amRNSAdditional Contract with West Midlands Police
11th Jul 20237:00 amRNSHalf-year Report
4th Jul 20237:00 amRNSContract Award
3rd Jul 20237:00 amRNSInvestor Presentation re interim results
19th Jun 20237:00 amRNSTrading Update and Notification of Results
11th May 20237:00 amRNSDirector dealings
2nd May 20237:00 amRNSNew Gaming Project in Asia
27th Apr 202311:51 amRNSResult of AGM
27th Apr 20237:00 amRNSAGM Statement
13th Apr 20237:00 amRNSContract Award
4th Apr 20238:09 amRNSDirector/PDMR Shareholding
23rd Mar 20237:00 amRNSPosting of Accounts and Notice of AGM
14th Mar 20237:00 amRNSPDMRs' Interests in Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.